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improvements in eye redness and irritation but no noticeable improvement in 
respiratory symptoms among treated students. Varying the number of solar 
products received within treatment households did not alter these results. This 
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Short-term Impacts of Solar Lanterns on Child Health: 
Experimental Evidence from Bangladesh
*
 
 
Yuya Kudo, Abu S. Shonchoy, Kazushi Takahashi 
 
We implemented a 16-month randomized field experiment in unelectrified 
areas of Bangladesh to identify health impacts of solar lanterns among 
school-aged children. Our analysis of various health-related 
indicators—self-reporting, spirometers, and professional medical 
checkups—showed modest improvements in eye redness and irritation but no 
noticeable improvement in respiratory symptoms among treated students. 
Varying the number of solar products received within treatment households 
did not alter these results. This limited health benefit was not caused by 
nonutilization of the products by treated children, spillover effects from 
treated to control students, or treatment heterogeneity resulting from 
unfavorable family cooking environments.  
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Indoor air pollution (IAP) is responsible for about 4.3 million deaths annually, 
and considered a leading environmental cause of deaths in the developing world (WHO 
2014; Hanna et al. 2016). IAP is mainly caused by use of kerosene and biomass fuels 
(e.g., wood, crop residues, cow dung), which emit considerable amounts of fine 
particulates, particulate matters (PM), carbon monoxide (CO), nitric oxides (NOx), and 
sulfur dioxide (SO2).  
Children in poor households are among the most susceptible groups to 
unfavorable health impacts of IAP for biological, environmental, and behavioral reasons 
(e.g., WHO 2005; Nandasena, Wickramasinghe and Sathiakumar 2013). For example, 
children require higher ventilation rates to absorb the required amount of oxygen 
compared to adults, because of their smaller alveoli (i.e., a hollow cavity found in the 
lung parenchyma). This leads them to breathe air pollutants deeply into their 
underdeveloped lungs (e.g., Bateson and Schwartz 2008; Saadeh and Klaunig 2014). In 
addition, children in developing countries—especially girls—often help their parents 
with cooking, thus spending long hours inside houses not equipped with chimneys or 
smoke hoods, highly exposing them to toxic IAP (e.g., Lam et al. 2012). The relevant 
smoke inhalation is often associated with a range of serious health problems, including 
respiratory/pulmonary diseases (e.g., asthma, bronchitis, chronic obstructive pulmonary 
disease (COPD), lung cancer, pneumonia, and wheezing) and some other symptoms 
(e.g., burn, eye strain, and cardiovascular disease) (e.g., Schwartz 2004). As a result, 
respiratory illnesses are listed as a major cause of child mortality and morbidity in 
developing countries (Pandey et al. 1989; Liu et al. 2015).  
Despite the significance of child health in the process of economic 
development (e.g., Currie 2009), economic studies on IAP and child health have lagged 
behind the epidemiological and medical literature (e.g., Smith-Sivertsen et al. 2004; 
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Díaz et al. 2007; Smith-Sivertsen et al. 2009). A handful of economic studies have 
emerged recently, most involving randomized control trials (RCTs). Examples of these 
efforts to date include investigations on the impact of improved cooking stoves, 
focusing on children as part of the targeted population (e.g., Duflo, Greenstone and 
Hanna 2008; Burwen and Levine 2012; Beltramo and Levine 2013; Bensch and Peters 
2015; Silwal and McKay 2015; Hanna, Duflo and Greenstone 2016). In contrast, very 
few empirical studies have examined the adverse health impacts of fuel-based lighting, 
which is another traditional source of IAP in developing countries (Apple et al. 2010). 
To the best of our knowledge, the only exception is a small-scale pilot project 
implemented by Furukawa (2012), who studied the health impacts of solar lanterns for 
155 upper primary school students in Uganda. 
To fill this significant knowledge gap, we conducted an RCT in the river 
islands located in northern Bangladesh (locally known as Chars), an area where most 
residents use kerosene-based equipment as a lighting source, to evaluate the impacts of 
solar lanterns on children’s respiratory function and a range of other health indicators. 
More precisely, we provided solar lanterns to a randomly selected 882 students 
belonging to the fourth to eighth grades in primary and secondary schools for 16 months 
(September 2013 to December 2014). We implemented a within-grade randomization at 
each school, and separated the sample students into three groups, i.e., those who 
received a bundle of a main high-capacity solar device along with two smaller lanterns, 
those who received only one main high-capacity solar device, and the remaining control 
students that received no devices. The ratio of these students was approximately 5:4:9 
and no students that were offered solar products refused to take the offer in our 
experiment.  
This particular study setting was purposely selected for the following reasons. 
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First, while our sample students may not necessarily belong to age cohorts that are the 
most biologically vulnerable to adverse effects of IAP, children in the fourth to eight 
grades rely on fuel-based traditional lighting sources (e.g., kerosene lamps) for 
nighttime study, which may have significant negative effects on children’s health (e.g., 
Pinkerton and Joad 2000; Selevan, Kimmel and Mendola 2000; Schwartz 2004; Saadeh 
and Klaunig 2014). To successfully progress to the next grade, students in these grades 
need to study harder at night than elementary grade children. Consequently, their 
exposure to health-related risk attributed to traditional lighting devices is likely to be 
more serious, which may increase marginal health returns for solar products.  
Second, because Chars are prone to cyclical river erosion and floods, the Rural 
Electrification Board (REB) of Bangladesh has no plans to expand national grid-based 
electricity to this region. Since solar products should be provided for people in such 
geographically challenged areas according to the present policy discourse, our study 
area has direct policy relevance (UNEP 2014). Moreover, as portable solar lamps were 
unavailable when we started this experiment, any potential contamination would be less 
serious in our study setting. 
Third, we expect that providing multiple solar lanterns and differentiating 
treatment intensity would increase the likelihood of intended use of solar products by 
targeted students, as other family members may also want to use the solar products for 
their own purposes. 
To assess the research outcomes, we collected a wealth of information on 
children’s health by utilizing numerous data collection opportunities, including a 
standard household survey module (July-August 2013 for the baseline and July-August 
2014 for the follow-up), periodic (repeated) health surveys (October 2013, January 2014, 
and April 2014), and doctors’ health checks (i.e., health camp) (November-December 
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2014). Spirometers were also utilized to measure respiratory capacity. This abundance 
of health indicators allowed our study to analyze trends of health conditions, making the 
analysis highly fruitful. In addition, during the health camp, we did not disclose the 
treatment status of the sample students to the medical professionals. Therefore, there is 
no systematic error in their diagnosis that may be correlated with personal views on the 
effectiveness of solar lanterns.  
A companion paper of this study (Kudo, Shonchoy and Takahashi, 
forthcoming) revealed that treated households utilized the solar products primarily for 
children’s study. Households that received solar products reduced annual kerosene 
expenditure by more than 50% compared with control households. Treated students also 
significantly reallocated time use for home study, reducing daytime while increasing the 
nighttime hours. This reallocation resulted in a net increase in total hours studied at 
home. Most notably, treated students substituted kerosene lamps with solar lanterns 
almost “perfectly” in order to study at night. This behavioral change encouraged us to 
expect sizable health impacts from solar products on the treated children. 
However, the findings yielded by the present study were not as encouraging as 
expected. As a set of positive results, we found treated students who received solar 
lanterns had significantly reduced eye problems, such as eye redness and irritation. 
Frequency of fire-related injuries, such as burns, was lower for students who received a 
bundle of three solar products. However, treated students (and their families) did not 
significantly improve in subjectively and objectively measured health outcomes related 
to respiratory and pulmonary symptoms. Our field observations and a range of 
robustness checks suggest that these limited impacts on respiratory systems are not 
attributable to nonutilization of the solar products, spillover effects resulting from the 
within-grade randomization, or treatment heterogeneity by use of unfavorable cooking 
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technologies that tend to worsen IAP. 
Overall, our study finds that solar lanterns have modest impacts on child health, 
at least in the short term. This finding is consistent with Furukawa (2012), who showed 
modest health improvements among treated students, especially during exam periods, 
compared to control students using kerosene candles. Solar lamps relax only one type of 
exposure risk to indoor air pollutants. Consequently, our findings may suggest that 
improving the home-energy environment only through provision of solar lanterns may 
have a limited impact on children’s health unless other types of exposure risk are 
simultaneously addressed (Nandasena et al. 2013). 
This study mainly contributes to two strands of the extant economic literature. 
First, given unfavorable effects of air pollution on child health (e.g., Currie and Neidell 
2005), we address this issue with a focus on home environments. Second, while 
research on improved cook stoves has been increasing as described above, we explore 
the health issue of IAP by conducting a large-scale RCT relevant to fuel-based lighting 
sources for the first time. 
The rest of the paper is organized as follows. Section I explains the study 
setting, sampling framework, and experimental design. Section II describes the data and 
summary statistics, followed by the estimation strategies in Section III. Section IV 
discusses the estimation results and implements robustness check. Section V provides 
our conclusions. 
 
I. Survey and Experimental Design 
A. The Study Area 
Our study area is the river islands, locally known as Chars, located in northern 
Bangladesh, which are formed by sediments and silt depositions. These islands are 
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extremely vulnerable to flooding and erosion, periodically during the rainy season (June 
to October) as monsoon precipitation coupled with excessive glacier melting of the 
Himalayas usually results in overflows of the major river channels of Bangladesh. 
Floods frequently result in loss of economic activity, possessions and earnings of Char 
dwellers, who need to escape to emergency shelters during floods.  
The provision of electricity is almost nonexistent in Char areas. Several NGOs, 
such as Grameen Shakti, have tried to provide Solar Home Systems (SHS), but so far 
these have not been adopted widely in Chars for at least two reasons: first, SHS is 
generally quite expensive for the ultra-poor Char dwellers; and second, since SHS is not 
a mobile utility, Char dwellers cannot remove it during flood-induced 
relocations—when the demand for electricity is high—or they may lose it following 
land erosion. Thus, investment in SHS in Char remains uncommon. Some households 
use battery–powered torchlights to supplement their emergency use, but these lights 
provide insufficient illumination to undertake most productive activities at night and the 
cost of batteries is generally too expensive for Char dwellers. Hence, most Char 
residents rely heavily on kerosene-based equipment as their main source of lighting.  
 
B. Solar Devices 
To study the impact of portable solar lanterns on child health, we used d.light 
solar lanterns, which are certified and recognized under the World Bank Lighting Global 
Project (https://www.lightingglobal.org/). d.light design, a social enterprise in California, 
US, has recently released a series of low cost, portable solar lights that are durable, 
weather resistant and have the capacity to produce bright white light through LED bulbs. 
We introduced the following three types of solar lanterns in this study (see also Figure 
I):  
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S250 is d.light’s flagship product, providing bright white light for a maximum 
of 4 hours and illuminating a room to the same degree as a 3 to 5-watt compact 
fluorescent lamp (CFL). It could provide on an average 110 lumens of light based on 
top brightness setting after a full day’s solar charge, and has the functionality of 
charging cellular phones. The S250 has a separate lightweight solar panel that needs to 
be used to recharge the unit. 
S10 is a high-quality solar light-emitting diode (LED) lamp that provides 
approximately 29 lumens of light for a maximum of 4 hours. This unit is handy, and can 
be used for studying or working as a portable flashlight, but it cannot be used to charge 
mobile phones. The solar panel of the S10 is embedded in the main unit.  
S2 is the simplest LED, which provides a focused, approximately 25 lumens of 
light for a maximum of 4 hours. The illumination capacity of this unit is lower than that 
of the other two units. Like the S10, this unit also cannot be used for charging mobile 
phones. The solar panel of the S2 is also embedded in the core unit.  
 The product costs of S250, S10, and S2 are about 40, 13.5 and 10 USD, 
respectively. Most of the poor in rural Bangladesh can pay these costs under a flexible 
or installment-based payment system, successfully implemented by NGOs like 
Grameen Shakti. In total, we obtained 500 units of the d.light S250, along with 
additional 300 units of the S10 and the S2. The procurement of those devices was 
supported by a generous contribution from BRAC, one of the world’s largest NGOs 
based in Bangladesh, and social business funds from Daiwa Securities through 
collaboration with Kopernik. Gana Unnayan Kendra (GUK), a northern-based NGO in 
Bangladesh, served as our implementation partner of this research. 
 
C. Sampling Structure and Experimental Design 
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 We targeted children attending primary (4
th
 to 5
th
 grades) and secondary (6
th
 to 
8
th
 grades) schools as the main sample for this study. To minimize contamination effects, 
those who lived in regions with limited access to modern electricity were given priority. 
We initially listed up all primary and secondary schools located in eight Chars of the 
Gaibandha and Kurigram districts of northern Bangladesh and implemented initial 
quick inspections with School Management Committees (SMCs) on the accessibility of 
electricity in April 2013. Out of a total 28, 17 primary or secondary schools in two 
Chars were found to have limited coverage of SHS. From 1,665 total students 
belonging to the fourth to eighth grades in those 17 schools, we selected 1,292 students 
as potential candidates for this study, whose homes (including school dormitories) had 
not been already electrified, whose siblings were not in the 1,292 students already 
chosen (i.e., for each household, we included only one child in our study sample) and 
whose school attendance rates in the past four months were not less than 80% (so that 
we can trace students with higher probability). We then interviewed all 1,292 children at 
his or her home and identified that 911 had actually no access to modern clean 
electricity at the time of survey. Of those, 882 became the effective sample; the rest 
dropped out of school before the implementation of the detailed household survey due 
to marriage or forced relocation resulting from flooding and river erosion.  
 The baseline survey was implemented in July-August 2013 for 882 children 
and their households. The survey collected detailed data pertaining to household 
demographic characteristics, health conditions of each household member, details of 
energy use and its sources, and expenditures. Health outcomes were elicited on a 
self-reporting basis; respondents (usually a household head or her/his spouse) reported 
disease experiences of all household members for the three months prior to the 
interview.  
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Once we completed the baseline household survey, we organized a public 
lottery at each sample school for each grade separately, to randomly allocate to the 
eligible students access to solar lights for 16 months (September 2013-December 2014). 
Students and their parents drew a lottery by themselves in the presence of other parents, 
teachers and village elites. Based on the lottery, students were assigned to one of the 
following three groups: (1) Treatment A, which received all the d.light solar products, 
i.e., the S250, the S10, and the S2, altogether providing approximately 164 lumens of 
lighting capacity at top brightness settings; (2) Treatment B, which received only the 
S250 solar lantern, providing lighting capacity of 110 lumens at the maximum 
brightness setting; and (3) the control group that did not receive any solar lantern.  
By differentiating the number of solar products across treatment arms, we 
intended to examine whether the provision of smaller lanterns had any additional 
impacts. For example, if other members of the treated households were willing to use 
the solar lanterns for their own use (for example, for nighttime social interaction), the 
impact of the solar lanterns on the targeted students would be reduced. Hence, bundling 
additional solar products may have increased the probability that target students enjoy 
the benefits of solar products. 
The ratio of Treatment A, Treatment B, and control groups was kept at 
approximately 5:4:9 for each grade at each school. After the public lottery, we ended up 
with 248 students in Treatment A, 198 students in Treatment B, and 436 students in the 
control group. In our experiment, no students that were offered solar products refused 
the offer.  
One potential threat to our experiment was failure to fully re-charge solar 
products, which can decrease the impact. To effectively recharge them, obstructions to 
sunlight (e.g., walls, trees) needed to be avoided. Furthermore, the tilt angle of the panel 
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under sunlight was also important for adequately recharging the lanterns. To facilitate 
proper maintenance and the correct recharging practice, we invited a product manager 
from the capital city, Dhaka to the study site to train our enumerators, who in turn 
instructed the survey respondents and their children. Furthermore, to ensure that these 
instructions were readily available for sample households, we provided a detailed 
pictorial manual to each household. This manual contained elaborate information on the 
adequate use/maintenance and recharging techniques of the solar lanterns.  
One year after the baseline survey, we implemented a follow-up study of the 
same children and their households in July-August 2014 to examine whether any 
welfare and behavioral changes had taken place over one year. During the follow-up 
phase, we could trace 852 of these households; the rest were lost due to attrition for 
such reasons as relocation or marriage.  
 
II. Data 
A. Health Indicators 
 With respect to outcomes, we first focus on respiratory symptoms and lung 
functioning of the target students that might be improved if solar lanterns successfully 
reduce their exposure to indoor air pollution. To examine this hypothesis, we use 
information measured in three different ways as follows.  
First, we use self-reported outcome indicators, such as cough, runny nose, and 
phlegm for the target students, collected in the July-August 2014 follow-up household 
survey.  
Second, we visited sample schools every three months from October 2013 to 
April 2014 to objectively measure lung capacities of students, such as forced expiratory 
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volume in one second (FEV1)
1
 and forced vital capacity (FVC),
2
 using a spirometer.  
Third, we implemented an independent “health camp” at each sample school 16 
months after initial distribution of solar lanterns in November to December 2014. These 
health camps were held to measure the following: FEV1, FVC, lung noise, postnasal 
drip, breath-holding time (in seconds), and heart beats per minute after a short run. 
These “health camps” were administered with professional doctors and health 
practitioners. Importantly, as the doctors were unaware of the treatment status of the 
sample students, their beliefs about effectiveness of solar products were less likely to 
affect their diagnosis in a systematic manner.  
While respiratory symptoms and lung functioning were our primary outcomes 
of interest, we also examined how treatment status changes the incidence of injuries and 
symptoms often associated with use of kerosene-based lighting devises, such as eye 
health, burns, skin diseases, headache and dizziness. To do this, we utilized both 
self-reported and health camp data. Annual medical expenditures spent on targeted 
children were also analyzed. 
 
B. Summary Statistics and Balancing Test 
By treatment arms, Table I and Table II present summary statistics of key 
household-level characteristics of the sample students at baseline. On average, a 
household consists of slightly less than five members, and is headed mostly by males 
with minimal education. Households in the study site seem to be extremely poor 
because their average total farm land area is about 10 decimals (about 1/10 acre), along 
with annual per-capita household expenditures of 16 thousand Taka (about 208 USD as 
                                                   
1
 This is the amount of air one can blow out within one second. 
2
 The total amount of air that one can blow out in one breath. 
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of July, 2013).  
[Table I and II about here] 
By experimental design, no sample household had prior access to solar lanterns 
in the baseline; instead they relied heavily on kerosene-based products (Table II). 
Almost all households owned kerosene-based lighting devices, such as open-wick 
kerosene lamps and covered-wick kerosene lanterns, known as “Hurricanes.” As 
kerosene lanterns are more expensive than lamps, most households possess and use the 
latter lighting devices rather than the former. Annual expenditure on kerosene is about 
1,600 BDT, accounting for approximately 10% and 2% of nonfood and total household 
expenditure, respectively.  
Most households under study have a single-room house, where they do cooking 
and other activities simultaneously. Only a quarter of households have any windows in 
the kitchen space. In the rainy season (June to October), almost all households cook 
inside in an enclosed area, which may intensify smoke exposure, while in the off-rainy 
season (November to May), approximately 60% of households cook outside. 
Table III reports summary statistics of individual characteristics of the targeted 
students. They were, on average, 12 years old with about 5.6 years of the highest 
education attained. Approximately 27% of students reported having some respiratory 
problems (i.e., cough, sore throat, runny nose, and phlegm) within the three months 
preceding the baseline survey. Headaches, a runny nose, and coughs were among the 
major health problems students had suffered. In contrast, very few students reported 
experiencing burns or skin diseases. The bottom of Table III indicates the baseline 
outcomes of FEV1 and FVC, measured by spirometer. The mean of FEV1/FVC×100 is 
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less than 60%,
3
 indicating that many students suffered COPD at the moderate level at 
the baseline.
4
  
[Table III about here] 
 To assess whether the randomization worked well, Table I, II and III also report 
p-values on the difference in means between treated and control households/students. 
While a few variables reveal statistically significant differences across the treatment 
arms, most variables are reasonably well balanced. Hence, we ascertain that the 
randomization in this study was overall successful.  
 
III. Empirical Framework 
Providing solar lamps may affect children’s health both directly and indirectly. 
Solar lanterns may reduce indoor smoke emissions if they effectively replace kerosene 
lamps. Solar lamps may also induce changes in students’ time use. For example, as 
found in Kudo, Shonchoy and Takahashi (forthcoming), our treated students 
significantly reduced daytime study hours while increasing nighttime study. This 
behavioral change might have increased children’s daytime activities outside their 
homes and thus, their exposure to outdoor air pollutants even if the risk of exposure to 
indoor air pollutants decreased due to the use of the solar products. Therefore, this study 
only identifies the total effects of these two forces on children’s health. 
Our experimental design enabled us to overcome a potential endogeneity 
problem often embedded in observational studies. We estimate an intention-to-treat 
(ITT) effect to identify the causal relationships between the provision of solar lanterns 
                                                   
3
 FEV1 divided by FVC (FEV1/FVC) shows the proportion of air that one can exhale in one second, 
of the total amount of air that the person can blow out in one breath. 
4
 Based on the estimation of Global Lung Function (GLF)-2012, the lower limit of normal (LLN) 
values for males aged 10-15 is 0.73-0.81 and for females is 0.77-0.84.   
15 
 
and outcomes of interest. Since no household refused our offer of solar lanterns, our ITT 
estimates are equivalent to the average treatment effect (ATE).  
Depending on the availability of the relevant baseline information, the 
following two reduced-form empirical models are employed. First, for health-related 
outcomes whose pre-experimental information is unavailable (e.g., data via medical 
health checkup), we estimate the following model: 
𝑌𝑖𝑗,𝐴 = 𝛼0 + 𝛼1𝐷1𝑖𝑗 + 𝛼2𝐷2𝑖𝑗 + 𝑋𝑖𝑗,𝐵𝛿 + 𝜇𝑗 + 𝜀𝑖𝑗, 
where 𝑌𝑖𝑗,𝐴  is postexperimental health conditions of a student i (or a household 
member i for some outcomes) living in a village j; D1 (D2) is an indicator for the 
treated households that received Treatment A (Treatment B); the vector 𝑋𝑖𝑗,𝐵 contains 
several baseline characteristics of the respondents, including students’ age (years); their 
gender (dummy); their completed education (years) (which is nearly equivalent to the 
child’s grade); household size; the number of males in a household; age of household 
heads (years); head’s gender (dummy); head’s education attainment (years); and 
household land size. The village- and school-grade fixed effects and a stochastic error 
term are represented by 𝜇𝑗 and 𝜀𝑖𝑗, respectively. 
When both the pre- and post-experimental health measures of students (or 
household members) are available, we apply an analysis of covariance (ANCOVA) 
model, following McKenzie (2012), which can be written as: 
𝑌𝑖𝑗,𝐴 = 𝛽0 + 𝛽1𝐷1𝑖𝑗 + 𝛽2𝐷2𝑖𝑗 + 𝑋𝑖𝑗,𝐵𝛿 + 𝛾𝑌𝑖𝑗,𝐵 + 𝜇𝑗 + 𝜀𝑖𝑗, 
where 𝑌𝑖𝑗,𝐵 is the pretreatment outcome variable.  
The random assignment of treatment arms should make the treatment and 
controls groups similar across all dimensions, according to expectation. Therefore, 
including the baseline controls 𝑋𝑖𝑗,𝐵 in regressors and/or applying the ANCOVA model 
would not affect the consistency of the estimated treatment effects. However, when 
16 
 
exploiting sub-samples that include some baseline differences across treatment arms, 
the inclusion of additional controls is expected to lend greater credit to internal validity 
of the estimates of interest. Thus, this study presents the results with baseline controls.
5
 
Throughout the study, we exploit ordinary least squares (OLS) estimations. 
Standard errors are adjusted for clustering in grades within the same school (39 groups) 
for outcomes of the target students, while plausibly avoiding a statistical inference 
problem arising from exploiting few clusters (Cameron and Miller 2015). For the sake 
of brevity, coefficients on several controls are suppressed when reporting the estimation 
results.6   
The number of observations differs equation by equation due to the different 
timing of data collection. Some students temporarily failed to attend school because of 
sickness or assistance with housework, while others left school due to relocation, 
marriage, and so on. This sample attrition may be problematic for our analysis if it is 
correlated with treatment status. Thus, we investigate whether this attrition issue 
reduces the internal validity of our estimates in Section IV. D, which addresses a range 
of robustness checks.  
 
IV. Estimation Results 
A. Respiratory Systems 
Table IV presents the estimation relevant to the targeted students, separately for 
self-reported outcomes, collected in July-August 2014 (Panel A), objective lung 
capacity measures, repeatedly collected every three months following the baseline 
                                                   
5 It should be noted, however, that exclusion of these controls had a negligible effect on the 
implications obtained from the regression analysis. 
6
 Full estimation results are available upon request.   
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survey (Panel B), and doctors’ evaluation in December, 2014 (Panel C). For Panel A and 
B, we have pretreatment outcome variables to control for, whereas for Panel C, we do 
not.  
The results in Table IV show that, overall, solar products do not significantly 
improve students’ recent respiratory symptoms. Indeed, as seen from Panel A, we find 
no average treatment effect on self-reported cough, sore throat, runny nose, or phlegm 
one year after the intervention.  
[Table IV about here] 
Similarly, we do not find any improvement in objectively measured lung 
functioning, such as FEV1 and FVC, for most observation periods.7 However, FVC 
among students that received all solar devices (Treatment A) moderately improved in 
January 2014, although this positive effect did not persist, and the statistical significance 
disappeared in April 2014. This finding is plausible because students tend to intensively 
study at night in November to December to pass the annual examination held in 
December (Kudo, Shonchoy and Takahashi, forthcoming), which makes them highly 
exposed to IAP just before January if they do not have solar lamps. This temporary 
health improvement detected in January is also in line with Furukawa’s (2012) finding 
that solar lanterns improved child health in Uganda during (or just after) the exam 
periods. However, as discussed in Section IV. D, this FVC improvement in January 
might also have resulted from a possible selection problem attributed to sample attrition. 
Finally, similar to the influence on self-reported respiratory problems, Panel C 
illustrates that professional medical practitioners also did not detect any significant 
improvements in a wide range of respiratory systems among treated students, including 
                                                   
7
 While not shown in Table, FEV1/FVC did not improve statistically significantly in all observation 
periods.   
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FEV1, FVC, lung noise, postnasal drip, the time of length (seconds) students can hold 
their breath, and heart beats per minute after a short run.  
 
B.  Other Symptoms Related to Fuel-Based Lighting Use 
 Turning to other health hazards relevant to the targeted children, Panel A of 
Table V shows null impact of solar lanterns on self-reported symptoms, such as 
headache and skin diseases, as well as annual medical expenditure. On the contrary, 
Panel B reveals that the incidence of burns detected by doctors is negative and 
statistically significant for treated students who obtained all three solar devices (Column 
(e)). Moreover, regardless of receiving all three devices or only main device, a 
statistically significant improvement is observed for eye-related problems, such as red 
eyes and eye irritation (Columns (f) and (g)), which were reduced by approximately 
14% and 10-14% points, respectively. 8  This reduction is not negligible, as the 
proportion of controlled students that suffered from these symptoms was about 26% and 
22%, respectively. 
[Table V about here] 
Overall, our results suggest that providing solar lanterns have negligible 
impacts on respiratory symptoms and lung functioning, but have moderate positive 
impacts on other kerosene-related problems, such as eye redness and burns. Similar 
implications are obtained in regressions pooling the two treatment arms into one (see 
Appendix A for details).  
 
C. Heterogeneity: Age, Gender and Cooking Environments 
                                                   
8
 F-test on the equality of the coefficient fails to reject the null hypothesis that the coefficients on the 
treatment A and B are statistically equivalent in Columns (f) and (g) in Panel B. 
19 
 
One of the potential reasons for the overall insignificant impacts on most health 
indicators is that health benefits of solar lanterns are observed only for a subset of our 
sample. We presume that there are three main sources of treatment heterogeneity that 
deserves attention.  
First, the negligible effects in our regressions might be because students’ 
respiratory capacities were too weak to recover immediately, due to their long-term 
exposure to IAP in early childhood. If this is true, we may observe impact heterogeneity 
across age, where older students are less likely to benefit from our interventions. To 
check this formally, we ran additional regressions with treatment status interacted with 
age. The results in Appendix B show that treatment effects, such as improved FVC in 
October 2013 and reduced eye problems in December 2014, decrease with age, 
providing supporting evidence on the above hypothesis. However, given that most 
coefficients remain statistically insignificant, age heterogeneity may not be a major 
reason for the overall absence of improvements in respiratory functions and other 
symptoms among treated students. 
Second, treatment effects may differ by gender of the students. For example, 
since females are mostly responsible for cooking in the study area, girls may be more 
exposed than boys to air pollutants caused by unfavorable indoor cooking technologies. 
In such a case, only replacing kerosene lamps/lanterns (for nighttime study) with solar 
products might not have been sufficiently effective to improve girls’ health conditions 
such as respiratory function. However, this conjecture is not supported in Appendix C, 
which investigates gender-differentiated impacts of solar lanterns. The table shows that 
the previously obtained implications remain unchanged, although we observed some 
evidence that suggests treated girls enjoy additional benefits in terms of reducing teary 
eyes.  
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Third, heterogeneity may also exist in terms of family cooking environments. 
As we argued previously, replacing kerosene lamps/lanterns with solar products might 
not be sufficient if PM concentrations associated with fuel-based cooking are 
responsible for most respiratory problems. To explore this conjecture, we construct 
interaction terms between treatment status and baseline cooking conditions, such as a 
typical place of cooking (inside or outside) in the off-rainy season, and whether a 
kitchen has a window. The estimated results, presented in Appendix D, show that 
impacts of solar lanterns do not substantially differ by cooking conditions, except for 
FEV1 that improved among treated households with all three products and no window 
in a kitchen space. In the absence of no other notable effects, we might say that 
treatment heterogeneity by unfavorable cooking environments may be less responsible 
for the overall null impacts.  
 
D. Robustness Check 
Hitherto, we have found limited effects of solar lanterns on health outcomes of 
the targeted students, especially for respiratory symptoms. Several potential threats to 
our findings are discussed here from the perspectives of (1) student usage of solar 
products, (2) sample attrition, (3) spillover effects, and (4) multiple-hypothesis testing. 
First, it is possible that treated students did not use solar lanterns properly or 
regularly. However, as briefly summarized in the Introduction, the treated households 
indeed utilized the solar products, primarily for children’s study (Kudo, Shonchoy and 
Takahashi, forthcoming). Nevertheless, to further address this concern, the present study 
also examined whether health outcomes of household members excluding the targeted 
students were significantly different between the treated and control groups. Significant 
health improvement of those members belonging to treated households may suggest that 
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they primarily utilized solar lamps, rather than the targeted students. We used the 
self-reported data from the follow-up survey in July-August 2014. The standard errors 
were clustered at the village level (42 groups) here, as not all family members currently 
attend school and this treatment allows for arbitrary correlations across households 
within a village. Baseline controls included only household level variables. Results in 
Table VI provide no evidence suggesting that other family members prevented treated 
students from using solar lamps. On respiratory-related and other symptoms in Panel A, 
we find no significant difference between treated and control households for most 
outcome variables. Gender-differenced effects in Panel B and C also show that the 
obtained implications are almost similar to the previous ones, although we see some 
reductions in runny nose among males as well as dizziness and skin disease among 
females. 
[Table VI about here] 
Second, sample attrition occurred: while we could trace most households in the 
follow-up survey (i.e., 96% of the 882 original sample students), the number of 
observations dropped sharply when the health camp was conducted. Our statistical 
inference may not be valid if attrition changes the composition of treatment and control 
students in a systematically different manner. Lee (2009) demonstrated that in RCT 
settings, if the sample attrition rates are similar between the treatment and control 
groups, a simple comparison between these groups can still be interpreted as a valid 
average treatment effect on the sub-population that would always be observed 
regardless of the treatment assignment. Accordingly, we examined whether the rate of 
sample attrition differed by treatment status for each timing of the data collection. We 
estimate a linear probability model with baseline controls, where the dependent variable 
takes one if an individual is observed at the time of survey. The results in Appendix E 
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indicate that except for January 2014 (i.e., FEV1 and FVC data collection), there is no 
differential attrition across the treatment and control groups. This indicates that attrition 
can be a source of bias for weekly positive impacts on FVC found in January 2014 
(Column (h) in Table IV), whereas it does not affect our statistical inference in most 
other outcomes.  
Third, given that our randomization is conducted within a specific grade level 
at each sample school, an obvious concern is spillover. For example, if treated students 
share their solar devices with control students for study or other purposes at night, the 
impacts can be attenuated. However, we do not believe that this is valid for our study, as 
visiting a friend’s home at night in unelectrified river islands is quite risky for both boys 
and girls. Indeed, in the follow-up household survey, we collected information on 
whether treated students shared solar lamps with nonhousehold members, and identified 
only three such cases, where solar lamps were shared with cousins. This field 
observation and side evidence support that negligible impacts on health outcomes 
cannot be attributed to spillover effects from treated to control students. Moreover, 
unlike infectious illnesses such as intestinal parasites (e.g., Miguel and Kremer 2004), 
disease externality is not a serious concern for health outcomes of our interest.  
 A final robustness check is to determine whether we have mistakenly detected 
significant positive impacts on eye problems and burns. Since many outcome variables 
are analyzed, we might obtain statistically significant effects simply by chance. We 
apply correction methods for multiple-hypothesis-testing. To do so, first, we reduced the 
number of tests being performed by pooling the two treatment groups into one and 
reported the estimation results for the overall treatment effect (Appendix A). Second, we 
employed the adjusted p-values following Theorem 3.1 of List, Shaikh and Xu (2016), 
along with a well-known Bonferroni procedure and Holm (1979)’s stepdown adjustment 
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procedure. Since the latter two procedures do not account for a dependency structure 
across tests when controlling a familywise error rate, they tend to reveal low statistical 
power. Nevertheless, we still observe significant solar impacts in relation to eye 
problems in Appendix F reporting the adjusted p-values. Overall, the previous findings 
still hold in this consideration of multiple-hypothesis testing. 
 In summary, we find modest improvements in child health caused by the 
introduction of solar lanterns. While it was hypothesized that substitution of solar 
lanterns for kerosene-based lighting mitigates respiratory symptoms by decreasing 
exposure to indoor air pollution, there was virtually no such effect for target students or 
their family members. Robust positive health effects we observe are limited to the 
reduction of eye problems, such as eye redness and irritation, among treated students.  
 
V. Conclusions 
It has been recognized that the widespread use of biomass and kerosene fuels 
for the source of lighting in developing countries have adverse impacts on pulmonary 
health, especially among children. Governments, policy makers and international 
donors have started to pay attention to finding effective ways to mitigate such adverse 
impacts. One approach towards such a goal is the provision of solar lanterns, which are 
clean, renewable, and relatively less expensive products, even for the poor, who rely 
heavily on traditional biomass based lighting sources.  
To evaluate the impact of solar lanterns on child health, we conducted a 
randomized field experiment in river islands of northern Bangladesh, where off-grid 
electricity is not available, and both susceptibility to climate risks and 
underdevelopment of transport infrastructure make its development difficult in the near 
future. 882 students are selected as a sample for this study, who attended the primary 
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and secondary schools and who had no access to modern electricity during the baseline 
survey. After random allocation of three solar products, only one product, and no 
products to a subset of sample students, we traced all students for 16 months from 
September 2013 to December 2014 and collected detailed information on health 
indicators.  
We obtained two major findings from this study. First, provision of solar 
lanterns resulted in, on average, no detectable improvement in a wide range of 
respiratory symptoms or lung capacity. Second, however, solar lanterns significantly 
decreased the presence of eye problems among treated students. The negligible impact 
we found on respiratory conditions is not entirely attributed to nonutilization of the solar 
products or treatment heterogeneity resulting from use of traditional cooking 
technologies. Through robustness checks, we also showed that spillover effects 
benefitting control households, intensive usage of solar products by other family 
members, and sample attrition do not explain our main results.  
Our findings suggest that health effects, especially those on respiratory 
symptoms, are unlikely to immediately improve through simply substituting solar 
lanterns for kerosene-based lighting. Although there is a growing enthusiasm for the 
promotion of solar portable lights as a useful alternative to off-grid electricity and solar 
home systems in unelectrified areas (World Bank 2010), we may caution that impacts of 
solar lanterns on child health could be smaller than expected.  
Nonetheless, we admit that our experiment is contingent on and specific to the 
area and the period of study. Moreover, the ways of obtaining a new technology (e.g., 
either through leasing, free distribution, or purchasing from the market) could also 
affect use and socio-economic impacts. Thus, our results may not necessarily be 
generalizable. However, note that our experiment was conducted in a setting where 
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marginal returns to solar lanterns are likely to be large because of limited availability of 
other modern electricity and behavioral characteristics of the target students. 
Considering this point, it might be difficult to expect sizable health impacts in more 
modestly disadvantaged settings unless complementary health investments using 
savings from the reduced kerosene expenditures are made. Similarly, complementary 
interventions addressing other possible environmental and behavioral factors relevant to 
child health (e.g., cook stoves) may also be required. Since our data do not allow us to 
investigate this pathway further, we cannot rule out the possibility that solar lanterns can 
have positive effects on child health in long terms. Further research and longer-term 
evidence are clearly needed before asserting more concrete conclusions. 
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Table I. Baseline Summary Statistics of Sample Students (Household-level), 2013 
 
Note: Figures in parentheses are standard deviations. *** denotes significance at 1%, ** at 5%, and * 
at 10%. 
Total
All three
products
Only one
product
Control
(1) (2) (3) (4) (2)-(4) (3)-(4)
Household size 4.908 4.948 4.788 4.940 0.946 0.153
(1.284) (1.380) (1.106) (1.301)
Head's age 41.793 41.847 41.990 41.672 0.802 0.658
(8.604) (9.200) (8.104) (8.491)
Head's education 1.266 1.185 1.197 1.344 0.484 0.554
(2.833) (2.666) (2.792) (2.945)
Head is male 0.916 0.915 0.929 0.911 0.832 0.430
(0.277) (0.279) (0.257) (0.286)
Total land (decimal) 10.112 10.323 10.475 9.828 0.820 0.729
(25.996) (34.581) (21.025) (22.120)
Total expenditure per capita (000BDT) 16.181 16.529 16.386 15.890 0.149 0.288
(5.647) (6.131) (5.934) (5.209)
Sample size 882 248 198 436
p -value
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Table II. Use of Electricity and Household Expenditure, Baseline 2013  
 
 Note: Figures in parentheses are standard deviations. *** denotes significance at 1%, ** at 5%, and * at 10%.
Total
All three
products
Only one
product
Control
(1) (2) (3) (4) (2)-(4) (3)-(4)
No. of light sources
# Flashlight 0.113 0.089 0.111 0.128 0.142 0.556
(0.335) (0.312) (0.315) (0.355)
# Kerosene lanterns 0.244 0.242 0.253 0.241 0.976 0.768
(0.465) (0.474) (0.490) (0.449)
# Kerosene lamps 1.671 1.726 1.662 1.644 0.087* 0.725
(0.586) (0.628) (0.544) (0.579)
Per-day hours using light sources
Off-rainy season
Flashlight 0.414 0.329 0.414 0.462 0.182 0.661
(1.249) (1.175) (1.221) (1.302)
Kerosene lanterns 0.786 0.855 0.828 0.727 0.306 0.450
(1.610) (1.730) (1.748) (1.469)
Kerosene lamps 5.391 5.481 5.587 5.252 0.234 0.105
(2.417) (2.435) (2.427) (2.399)
Rainy season
Flashlight 0.295 0.226 0.313 0.327 0.149 0.862
(0.886) (0.792) (0.906) (0.926)
Kerosene lanterns 4.131 4.198 4.236 4.045 0.287 0.212
(1.787) (1.815) (1.761) (1.783)
Kerosene lamps 0.629 0.692 0.669 0.576 0.248 0.378
(1.290) (1.420) (1.391) (1.159)
Cooking environsment
Any window in a kitchen 0.226 0.206 0.192 0.252 0.167 0.096*
(0.418) (0.405) (0.395) (0.435)
Kichen is indoor (rainy season) 0.974 0.988 0.980 0.963 0.060* 0.272
(0.159) (0.110) (0.141) (0.188)
Kichen is indoor (off-rainy season) 0.410 0.415 0.369 0.427 0.774 0.170
(0.492) (0.494) (0.484) (0.495)
Household expenditure (000 BDT)
Kerosene 1.621 1.544 1.553 1.695 0.184 0.264
(1.307) (0.700) (0.735) (1.710)
Other energy 0.022 0.014 0.023 0.026 0.143 0.719
(0.101) (0.060) (0.084) (0.124)
Medical fee 2.173 2.119 2.206 2.188 0.644 0.916
(1.879) (1.652) (1.888) (1.996)
Total nonfood expenditure 17.345 17.425 17.046 17.436 0.981 0.374
(5.250) (5.608) (4.358) (5.413)
Total food expenditure 59.841 62.010 59.820 58.617 0.083* 0.582
(26.061) (27.463) (30.649) (22.754)
Total expenditure 77.186 79.435 76.866 76.053 0.114 0.728
(28.092) (30.045) (31.985) (24.864)
p -value
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Table III. Baseline Characteristics of Sample Students (Individual-level), 2013 
 
Note: Figures in parentheses are standard deviations. *** denotes significance at 1%, ** at 5%, and 
* at 10%.
Total
All three
products
Only one
product
Control
(1) (2) (3) (4) (2)-(4) (3)-(4)
Age 12.383 12.347 12.465 12.367 0.787 0.358
(1.523) (1.554) (1.611) (1.465)
Education 5.627 5.641 5.646 5.610 0.722 0.666
(1.397) (1.393) (1.409) (1.398)
Male 0.438 0.411 0.429 0.456 0.287 0.401
(0.496) (0.493) (0.496) (0.499)
Cough (=1) 0.100 0.117 0.107 0.087 0.130 0.313
(0.300) (0.322) (0.309) (0.282)
Sore throat  (=1) 0.012 0.004 0.020 0.014 0.218 0.561
(0.111) (0.064) (0.141) (0.117)
Runny nose  (=1) 0.209 0.238 0.239 0.179 0.032** 0.062*
(0.407) (0.427) (0.427) (0.384)
Phlegm  (=1) 0.034 0.028 0.025 0.041 0.361 0.304
(0.181) (0.166) (0.158) (0.199)
Headache (=1) 0.241 0.266 0.264 0.216 0.118 0.175
(0.428) (0.443) (0.442) (0.412)
Dizziness (=1) 0.003 0.004 0.000 0.005 0.905 0.337
(0.058) (0.064) (0.000) (0.068)
Skin disease (=1) 0.009 0.004 0.010 0.011 0.308 0.866
(0.095) (0.064) (0.101) (0.107)
FEV1 1.050 1.053 1.003 1.070 0.691 0.154
(0.542) (0.558) (0.514) (0.546)
FVC 1.853 1.818 1.809 1.894 0.147 0.119
(0.632) (0.633) (0.581) (0.653)
N 882 248 198 436
p -value
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Table IV. Impacts on Students’ Health: Respiratory Symptoms and Lung Function 
 
Notes: Figures in parentheses are clustered standard errors. *** denotes significance at 1%, ** at 5%, 
and * at 10%. The baseline controls include age (years); education (years); gender (dummy); 
household size; no. of males; head age (years); head education (years); head gender (dummy); and 
land size (natural number). Pretreatment outcomes are controlled for panel A and B. 
 
Panel A (Self-report)
Outcome Cough (=1)
Sore throat
(=1)
Runny
nose (=1)
Phlegm (=1)
(a) (b) (c) (d)
All products 0.008 0.000 -0.039 -0.005
(0.028) (0.016) (0.030) (0.004)
One product -0.031 -0.009 -0.043 -0.003
(0.027) (0.013) (0.037) (0.003)
N 816 816 816 816
Adjusted R-squared 0.108 0.100 0.101 0.097
Mean y (control) 0.134 0.037 0.192 0.005
Panel B (Repeated survey)
Outcome FEV1 FVC FEV1 FVC FEV1 FVC
(e) (f) (g) (h) (i) (j)
All products -0.043 -0.057 0.044 0.116** 0.035 0.003
(0.043) (0.043) (0.045) (0.055) (0.028) (0.032)
One product 0.010 -0.039 0.004 0.098 -0.009 -0.008
(0.045) (0.046) (0.045) (0.070) (0.035) (0.043)
N 789 789 667 667 771 771
Adjusted R-squared 0.270 0.452 0.244 0.144 0.204 0.105
Mean y (control) 1.050 1.887 1.042 1.806 1.263 1.713
Panel C (Health camp)
Outcome FEV1 FVC
Lung noise
(=1)
Postnasal
drip (=1)
Hold
breath
(sec)
Heart beat
per min after
a short run
(k) (l) (m) (n) (o) (p)
All products -0.036 0.012 0.007 -0.019 -0.265 0.001
(0.046) (0.057) (0.010) (0.027) (0.975) (0.696)
One product 0.000 -0.008 0.008 -0.049 -1.605 -0.065
(0.051) (0.052) (0.010) (0.030) (1.066) (1.043)
N 753 753 525 525 525 525
Adjusted R-squared 0.269 0.239 0.113 0.137 0.287 0.243
Mean y (control) 1.158 1.742 0.004 0.079 21.067 81.826
Jul/Aug- 14
Oct-13 Jan-14 Apr-14
Dec-14
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Table V. Impacts on Students’ Health: Other Diseases 
 
Notes: Figures in parentheses are clustered standard errors. *** denotes significance at 1%, ** at 5%, 
and * at 10%. The baseline controls include age (years); education (years); gender (dummy); 
household size; no. of males; head age (years); head education (years); head gender (dummy); and 
land size (natural number). Pretreatment outcomes are controlled for panel A. 
 
 
 
 
 
 
 
 
 
 
Panel A (Self-report)
Self-report
Headache
(=1)
Dizziness
(=1)
Skin disease
(=1)
Medical
expenditure
(BDT)
(a) (b) (c) (d)
All products -0.037 0.000 0.009 10.545
(0.037) (0.001) (0.007) (17.684)
One product -0.024 0.005 0.000 27.310
(0.036) (0.005) (0.001) (33.445)
N 816 816 816 813
Adjusted R-squared 0.137 0.056 0.048 0.084
Mean y (control) 0.366 0.000 0.000 396.5
Panel B (Health camp)
Health camp
Any visible
burn (=1)
Eye
redness
(=1)
Eye irritation
(=1)
Teary eyes
(=1)
Dimness of
vision (=1)
(e) (f) (g) (h) (i)
All products -0.045** -0.143** -0.137** -0.020 0.006
(0.022) (0.053) (0.051) (0.022) (0.009)
One product -0.001 -0.141*** -0.103* -0.034 0.002
(0.033) (0.051) (0.053) (0.020) (0.009)
N 525 525 525 525 525
Adjusted R-squared 0.130 0.228 0.232 0.099 0.123
Mean y (control) 0.075 0.257 0.217 0.043 0.004
Jul/Aug- 14
Dec-14
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Table VI. Impacts on Other Household Members’ Health 
 
Notes: Figures in parentheses are clustered standard errors. *** denotes significance at 1%, ** at 5%, 
and * at 10%. The baseline controls include household size; no. of males; head age (years); head 
education (years); head gender (dummy); and land size (natural number). Pretreatment outcomes are 
also controlled for.  
Cough (=1)
Sore throat
(=1)
Runny
nose (=1)
Phlegm
(=1)
Headache
(=1)
Dizziness
(=1)
Skin disease
(=1)
(a) (b) (c) (d) (e) (f) (g)
All  (Panel A)
All products 0.007 0.003 -0.026 0.001 -0.006 -0.000 0.002
(0.017) (0.004) (0.019) (0.002) (0.018) (0.004) (0.003)
One product 0.015 0.010* -0.012 0.008 0.007 -0.005** -0.003
(0.015) (0.006) (0.020) (0.006) (0.023) (0.002) (0.002)
N 3208 3208 3208 3208 3208 3208 3208
Adjusted R-squared 0.045 0.021 0.031 0.03 0.04 0.014 0.021
Mean y (control) 0.108 0.021 0.184 0.021 0.280 0.005 0.007
(h) (i) (j) (k) (l) (m) (n)
Male (Panel B)
All products 0.017 0.003 -0.040** 0.002 -0.000 0.002 0.004
(0.017) (0.004) (0.019) (0.004) (0.017) (0.004) (0.004)
One product 0.003 0.009 -0.022 0.013* 0.044 0.001 -0.002
(0.019) (0.007) (0.023) (0.007) (0.036) (0.004) (0.004)
N 1617 1617 1617 1617 1617 1617 1617
Adjusted R-squared 0.046 0.03 0.045 0.032 0.043 0.03 0.025
Mean y (control) 0.113 0.022 0.182 0.021 0.276 0.002 0.004
(o) (p) (q) (r) (s) (t) (u)
Female (Penel C)
All products -0.001 0.003 -0.014 0.000 -0.011 -0.003 -0.000
(0.018) (0.008) (0.028) (0.004) (0.037) (0.004) (0.003)
One product 0.031 0.008 0.002 0.004 -0.019 -0.012*** -0.004*
(0.019) (0.010) (0.031) (0.008) (0.024) (0.003) (0.002)
N 1590 1590 1590 1590 1590 1590 1590
Adjusted R-squared 0.064 0.021 0.045 0.041 0.057 0.022 0.052
Mean y (control) 0.102 0.020 0.186 0.020 0.282 0.009 0.010
Self-report
Jul/Aug- 14
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Appendix A. Impacts on Students’ Health: Any Treatment vs Control  
 
Figures in parentheses are clustered standard errors. *** denotes significance at 1%, ** at 5%, and * at 10%. The baseline controls include age (years); education (years); gender 
(dummy); household size; no. of males; head age (years); head education (years); head gender (dummy); and land size (natural number). Pretreatment outcomes are controlled for 
panel A and B.  
Panel A
Cough (=1)
Sore throat
(=1)
Runny
nose (=1)
Phlegm (=1)
Headache
(=1)
Dizziness
(=1)
Skin
disease
(=1)
Medical
expenditure
(BDT)
(a) (b) (c) (d) (e) (f) (g) (h)
Any treatment -0.009 -0.004 -0.040 -0.004 -0.031 0.003 0.005 17.906
(0.023) (0.012) (0.028) (0.003) (0.031) (0.002) (0.004) (18.048)
N 816 816 816 816 816 816 816 813
Adjusted R-squared 0.106 0.100 0.101 0.097 0.137 0.054 0.044 0.084
Panel B
FEV1 FVC FEV1 FVC FEV1 FVC
(i) (j) (k) (l) (m) (n)
Any treatment -0.020 -0.050 0.027 0.108** 0.015 -0.002
(0.039) (0.040) (0.038) (0.052) (0.026) (0.028)
N 789 789 667 667 771 771
Adjusted R-squared 0.268 0.452 0.243 0.144 0.203 0.104
Panel C
FEV1 FVC
Lung noise
(=1)
Postnasal
drip (=1)
Hold breath
(sec)
Heart beat
per min after
a short run
Any visible
burn (=1)
Eye redness
(=1)
Eye
irritation
(=1)
Teary eyes
(=1)
Dimness of
vision (=1)
(o) (p) (q) (r) (s) (t) (u) (v) (w) (x) (y)
Any treatment -0.020 0.003 0.008 -0.032 -0.855 -0.028 -0.025 -0.143*** -0.122** -0.026 0.004
(0.043) (0.049) (0.008) (0.025) (0.874) (0.767) (0.021) (0.047) (0.046) (0.020) (0.007)
N 753 753 525 525 525 525 525 525 525 525 525
Adjusted R-squared 0.268 0.239 0.112 0.136 0.285 0.243 0.126 0.228 0.231 0.098 0.122
Health camp
Dec-14
Self-report
Jul/Aug- 14
Repeated survey
Oct-13 Jan-14 Apr-14
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Appendix B. Heterogeneous Treatment Effects on Students’ Health: By Age 
  
Figures in parentheses are clustered standard errors. *** denotes significance at 1%, ** at 5%, and * at 10%. The baseline controls include age (years); education (years); gender 
(dummy); household size; no. of males; head age (years); head education (years); head gender (dummy); and land size (natural number). Pretreatment outcomes are controlled for 
panel A and B. Since Dizziness for male and Phlegm for female are perfectly predicted, they are dropped.
Panel A Panel B 
Cough (=1)
Sore throat
(=1)
Runny
nose (=1)
Phlegm
(=1)
Headache
(=1)
Dizziness
(=1)
Skin disease
(=1)
Medical
expenditure (BDT) FEV1 FVC FEV1 FVC FEV1 FVC
(a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m) (n)
All products -0.136 -0.020 0.257 -0.041 -0.245 -0.003 0.004 -85.981 -0.219 0.358 -0.020 0.332 -0.013 0.021
(0.218) (0.096) (0.231) (0.073) (0.343) (0.005) (0.039) (173.055) (0.348) (0.399) (0.390) (0.430) (0.239) (0.297)
One product 0.338 0.109 0.052 -0.027 0.159 -0.019 0.002 -80.179 0.370 0.842** 0.147 -0.014 -0.044 -0.185
(0.203) (0.118) (0.310) (0.046) (0.292) (0.019) (0.006) (156.001) (0.292) (0.372) (0.279) (0.658) (0.345) (0.324)
Age
X All products 0.012 0.002 -0.024 0.003 0.017 0.000 0.000 7.859 0.014 -0.034 0.003 -0.018 0.003 -0.001
(0.017) (0.008) (0.018) (0.006) (0.028) (0.000) (0.003) (14.481) (0.029) (0.032) (0.031) (0.035) (0.020) (0.024)
X One product -0.030* -0.010 -0.008 0.002 -0.015 0.002 -0.000 8.736 -0.028 -0.070** -0.013 0.010 0.002 0.014
(0.016) (0.010) (0.024) (0.004) (0.023) (0.002) (0.000) (14.508) (0.025) (0.030) (0.023) (0.054) (0.027) (0.026)
N 816 816 816 816 816 816 816 813 753 753 640 640 737 737
Adjusted R-squared 0.112 0.101 0.103 0.098 0.138 0.058 0.048 0.085 0.285 0.462 0.273 0.161 0.218 0.111
Panel 
FEV1 FVC
Lung noise
(=1)
Postnasal
drip (=1)
Hold
breath
(sec)
Heart beat
per min
after a
short run
Any visible
burn (=1) Eye redness (=1)
Eye
irritation
(=1)
Teary eyes
(=1)
Dimness of
vision (=1)
(o) (p) (q) (r) (s) (t) (u) (v) (w) (x) (y)
All products -0.109 -0.012 0.031 -0.129 10.908 1.881 0.206 -0.548 -0.506 -0.085 -0.058
(0.416) (0.564) (0.131) (0.176) (7.909) (4.523) (0.227) (0.446) (0.435) (0.183) (0.063)
One product 0.246 0.613 -0.015 0.030 8.988 5.876 0.181 -1.092*** -0.873** -0.205 -0.110
(0.349) (0.386) (0.052) (0.232) (9.350) (6.852) (0.193) (0.381) (0.422) (0.168) (0.069)
Age
X All products 0.006 0.001 -0.002 0.009 -0.922 -0.149 -0.021 0.033 0.030 0.006 0.005
(0.034) (0.047) (0.011) (0.013) (0.708) (0.350) (0.019) (0.035) (0.034) (0.015) (0.005)
X One product -0.022 -0.053* 0.002 -0.007 -0.884 -0.475 -0.015 0.079** 0.064* 0.015 0.009
(0.026) (0.030) (0.005) (0.018) (0.820) (0.507) (0.016) (0.030) (0.034) (0.014) (0.006)
N 720 720 501 501 501 501 501 501 501 501 501
Adjusted R-squared 0.28 0.244 0.116 0.142 0.291 0.253 0.148 0.252 0.251 0.106 0.133
Dec-14
Repeated survey
Health camp
Self-report
Jul/Aug- 14 Oct-13 Jan-14 Apr-14
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Appendix C. Heterogeneous Treatment Effects on Students’ Health: By Gender  
 
Figures in parentheses are clustered standard errors. *** denotes significance at 1%, ** at 5%, and * at 10%. The baseline controls include age (years); education (years); gender 
(dummy); household size; no. of males; head age (years); head education (years); head gender (dummy); and land size (natural number). Pretreatment outcomes are controlled for 
panel A and B. Since Dizziness for male and Phlegm for female are perfectly predicted, they are dropped.
Panel A Panel B 
Cough (=1)
Sore throat
(=1)
Runny
nose (=1)
Phlegm (=1)
Headache
(=1)
Dizziness
(=1)
Skin
disease
(=1)
Medical
expenditure
(BDT) FEV1 FVC FEV1 FVC FEV1 FVC
(a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m) (n)
Male
All products 0.011 -0.030 -0.067 -0.020 -0.063 - 0.010 -62.790** 0.021 -0.014 0.042 0.214*** 0.072 -0.045
(0.048) (0.023) (0.045) (0.014) (0.061) - (0.011) (24.241) (0.063) (0.063) (0.085) (0.072) (0.043) (0.050)
One product -0.033 -0.005 0.032 -0.011 -0.014 - -0.000 -23.346 0.002 -0.040 -0.032 0.123 -0.040 -0.008
(0.039) (0.027) (0.060) (0.008) (0.053) - (0.002) (26.209) (0.072) (0.059) (0.110) (0.094) (0.089) (0.061)
N 361 361 361 361 361 - 361 359 336 336 277 277 337 337
Adjusted R-squared 0.263 0.130 0.196 0.228 0.236 - 0.096 0.235 0.382 0.542 0.317 0.264 0.504 0.189
Female
All products -0.003 0.028 -0.030 - -0.059 -0.001 0.005 45.276 -0.070 -0.037 0.033 0.065 -0.018 0.008
(0.040) (0.019) (0.046) - (0.043) (0.002) (0.006) (31.925) (0.062) (0.076) (0.052) (0.068) (0.042) (0.047)
One product -0.015 -0.001 -0.097** - -0.065 0.010 -0.000 69.902 0.042 0.004 0.004 0.079 -0.042 -0.019
(0.050) (0.016) (0.038) - (0.056) (0.010) (0.001) (65.894) (0.058) (0.073) (0.044) (0.102) (0.048) (0.065)
N 453 453 453 - 453 453 453 452 445 445 388 388 429 429
Adjusted R-squared 0.160 0.268 0.152 - 0.188 0.083 0.087 0.096 0.253 0.281 0.239 0.185 0.184 0.175
Panel C
FEV1 FVC
Lung noise
(=1)
Postnasal
drip (=1)
Hold breath
(sec)
Heart beat
per min after
a short run
Any visible
burn (=1)
Eye
redness
(=1)
Eye
irritation
(=1)
Teary eyes
(=1)
Dimness of
vision (=1)
(o) (p) (q) (r) (s) (t) (u) (v) (w) (x) (y)
male
All products -0.105 -0.016 0.012 0.025 -1.567 0.841 -0.042 -0.173* -0.133 0.014 0.026
(0.074) (0.074) (0.013) (0.037) (3.267) (1.868) (0.046) (0.088) (0.097) (0.039) (0.029)
One product -0.040 -0.075 0.013 -0.017 -3.175* 0.523 0.030 -0.185** -0.091 -0.019 -0.008
(0.105) (0.075) (0.016) (0.039) (1.567) (2.386) (0.062) (0.070) (0.068) (0.023) (0.008)
N 328 328 205 205 205 205 205 205 205 205 205
Adjusted R-squared 0.247 0.199 0.274 0.359 0.347 0.323 0.231 0.342 0.308 0.218 0.594
female
All products 0.048 0.068 0.007 -0.047 -0.068 -0.252 -0.041 -0.139** -0.150** -0.055* -0.007
(0.042) (0.089) (0.014) (0.035) (1.194) (0.796) (0.033) (0.060) (0.060) (0.030) (0.008)
One product 0.031 0.008 -0.003 -0.053 -0.774 -0.330 -0.019 -0.124* -0.098 -0.053* -0.011
(0.043) (0.060) (0.005) (0.034) (1.219) (0.900) (0.041) (0.066) (0.073) (0.027) (0.010)
N 421 421 319 319 319 319 319 319 319 319 319
Adjusted R-squared 0.288 0.261 0.413 0.205 0.363 0.294 0.258 0.304 0.319 0.183 0.105
Health camp
Dec-14
Self-report Repeated survey
Jul/Aug- 14 Oct-13 Jan-14 Apr-14
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Appendix D. Heterogeneous Treatment Effects on Students’ Health: By Cooking Environments 
 
Cough (=1)
Sore throat
(=1)
Runny
nose (=1)
Phlegm
(=1)
Headache
(=1)
Dizziness
(=1)
Skin
disease
(=1)
Medical
expenditure
(BDT)
FEV1 FVC FEV1 FVC FEV1 FVC
(a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m) (n)
All products 0.045 -0.062 0.017 -0.008 -0.174* -0.001 0.027 -23.119 -0.193* -0.108 -0.249** 0.211* 0.018 -0.063
(0.059) (0.043) (0.087) (0.006) (0.101) (0.002) (0.024) (60.943) (0.100) (0.133) (0.106) (0.110) (0.124) (0.079)
One product -0.017 -0.021 0.082 -0.009 -0.101 0.007 -0.002 -28.629 0.101 0.150 0.005 0.320** 0.103 -0.164
(0.065) (0.064) (0.100) (0.007) (0.098) (0.007) (0.005) (78.253) (0.119) (0.151) (0.118) (0.156) (0.117) (0.110)
All products
X No window -0.020 0.089* -0.075 -0.001 0.118 0.001 -0.021 -9.848 0.168* 0.033 0.324** -0.094 0.050 0.048
(0.058) (0.047) (0.091) (0.004) (0.100) (0.002) (0.027) (60.257) (0.097) (0.137) (0.121) (0.115) (0.138) (0.087)
X Cook inside -0.056 -0.018 -0.007 0.008 0.091 0.001 -0.000 76.347* 0.023 0.040 0.001 -0.060 -0.096 0.085
(0.057) (0.028) (0.074) (0.006) (0.084) (0.001) (0.010) (38.097) (0.090) (0.083) (0.103) (0.112) (0.077) (0.059)
One product
X No window 0.040 -0.008 -0.120 0.001 0.090 0.002 0.002 40.834 -0.060 -0.209 0.001 -0.159 -0.117 0.124
(0.069) (0.066) (0.095) (0.005) (0.103) (0.003) (0.005) (78.727) (0.117) (0.153) (0.118) (0.164) (0.119) (0.125)
X Cook inside -0.094 0.050 -0.076 0.010 0.023 -0.009 0.003 67.819 -0.092 -0.025 -0.053 -0.199 -0.059 0.146
(0.057) (0.038) (0.064) (0.008) (0.106) (0.009) (0.003) (89.527) (0.104) (0.095) (0.083) (0.145) (0.096) (0.100)
No window 0.013 -0.041 0.037 0.001 -0.067 -0.001 -0.003 -15.659 -0.036 0.056 -0.081 0.049 0.047 -0.107*
(0.043) (0.027) (0.055) (0.004) (0.067) (0.001) (0.003) (22.049) (0.074) (0.090) (0.074) (0.083) (0.113) (0.057)
Cook inside 0.081** -0.019 0.022 -0.008 0.023 0.000 -0.001 -51.558** 0.032 0.063 0.096* 0.111* 0.091* -0.057
(0.038) (0.015) (0.041) (0.006) (0.056) (0.001) (0.001) (20.111) (0.051) (0.052) (0.054) (0.064) (0.053) (0.037)
N 779 779 779 779 779 779 779 776 753 753 640 640 737 737
Adjusted R-squared 0.125 0.120 0.119 0.103 0.147 0.061 0.058 0.084 0.287 0.461 0.285 0.164 0.222 0.116
Self-report Repeated survey
Jul/Aug- 14 Oct-13 Jan-14 Apr-14
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Appendix D (cont.)  
 
Figures in parentheses are clustered standard errors. *** denotes significance at 1%, ** at 5%, and * at 10%. The baseline controls include age (years); education (years); gender 
(dummy); household size; no. of males; head age (years); head education (years); head gender (dummy); and land size (natural number). Pretreatment outcomes are controlled for 
panel A and B.  
FEV1 FVC
Lung noise
(=1)
Postnasal
drip (=1)
Hold breath
(sec)
Heart beat
per min
after a
short run
Any visible
burn (=1)
Eye
redness
(=1)
Eye
irritation
(=1)
Teary eyes
(=1)
Dimness of
vision (=1)
(o) (p) (q) (r) (s) (t) (u) (v) (w) (x) (y)
All products -0.217** -0.084 0.031 0.037 -1.541 -0.363 -0.002 -0.148 -0.135 -0.034 -0.012
(0.094) (0.133) (0.034) (0.097) (3.830) (2.388) (0.048) (0.101) (0.085) (0.035) (0.020)
One product 0.140 0.158 0.006 -0.031 -2.962 0.245 0.015 -0.135 -0.062 -0.072** -0.017
(0.121) (0.100) (0.016) (0.082) (3.819) (2.246) (0.080) (0.081) (0.075) (0.031) (0.019)
All products
X No window 0.211** 0.092 -0.035 -0.048 2.395 -0.417 -0.075 -0.045 0.001 0.017 0.034
(0.086) (0.146) (0.041) (0.100) (3.978) (2.179) (0.053) (0.091) (0.080) (0.035) (0.025)
X Cook inside 0.010 0.029 0.014 -0.040 -1.390 2.030 0.042 0.089 -0.023 0.003 -0.024
(0.080) (0.137) (0.024) (0.069) (2.713) (2.266) (0.047) (0.092) (0.074) (0.032) (0.021)
One product
X No window -0.068 -0.207** 0.008 -0.012 1.036 -1.425 0.025 -0.080 -0.066 0.016 0.029
(0.100) (0.098) (0.015) (0.081) (3.695) (2.017) (0.079) (0.093) (0.077) (0.031) (0.023)
X Cook inside -0.273** -0.099 -0.010 -0.027 1.173 2.429 -0.075 0.125 0.020 0.067 -0.013
(0.105) (0.092) (0.019) (0.070) (2.200) (1.844) (0.056) (0.090) (0.090) (0.041) (0.013)
No window -0.028 0.016 0.002 0.009 -0.166 -0.600 0.055 0.036 0.042 0.006 -0.028
(0.041) (0.077) (0.009) (0.062) (3.399) (1.551) (0.033) (0.066) (0.060) (0.035) (0.021)
Cook inside 0.051 -0.000 -0.001 0.025 -0.096 -1.325 -0.039 -0.133** -0.047 -0.031* 0.006
(0.047) (0.065) (0.009) (0.053) (2.265) (1.180) (0.038) (0.060) (0.053) (0.017) (0.013)
N 720 720 501 501 501 501 501 501 501 501 501
Adjusted R-squared 0.294 0.245 0.124 0.143 0.290 0.258 0.156 0.245 0.243 0.109 0.139
Health camp
Dec-14
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Appendix E.  Testing for Sample Attrition   
  
Figures in parentheses are clustered standard errors. *** denotes significance at 1%, ** at 5%, and * 
at 10%. The baseline controls include age (years); education (years); gender (dummy); household 
size; no. of males; head age (years); head education (years); head gender (dummy); and land size 
(natural number).  
Data type
Follow-up
household
survey
Health
camp
Data collection period Jul/Aug- 14 Oct-13 Jan-14 Apr-14 Dec-14
(a) (b) (c) (d) (e)
All products 0.007 0.024 0.066* -0.009 0.029
(0.021) (0.020) (0.035) (0.025) (0.030)
One product -0.003 0.003 0.017 0.003 0.007
(0.020) (0.028) (0.041) (0.025) (0.033)
N 882 882 882 882 882
Non-attrition sample 816 789 667 771 525
Adjusted R-squqred 0.099 0.120 0.108 0.103 0.103
Repeated survey
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Appendix F. Checking on Multiple-hypothesis Testing for Selected Outcomes 
 
 
List et al., Bonferroni and Holm are q-values (p-values corrected for multiple testing) 
 
Variable Data collection period List et al. Bonferroni Holm
Cough (=1) Jul/Aug- 14 1.000 1.000 1.000
Sore throat (=1) Jul/Aug- 14 1.000 1.000 1.000
Runny nose (=1) Jul/Aug- 14 0.999 1.000 1.000
Phlegm (=1) Jul/Aug- 14 0.954 1.000 1.000
FEV1 Oct-13 1.000 1.000 1.000
FEV1 Jan-14 0.999 1.000 1.000
FEV1 Apr-14 1.000 1.000 1.000
FVC Oct-13 0.972 1.000 1.000
FVC Jan-14 0.852 1.000 1.000
FVC Apr-14 1.000 1.000 1.000
FEV1 Dec-14 1.000 1.000 1.000
FVC Dec-14 0.998 1.000 1.000
Lung noise (=1) Dec-14 1.000 1.000 1.000
Postnasal drip (=1) Dec-14 0.998 1.000 1.000
Hold breath (sec) Dec-14 0.976 1.000 1.000
Heart beat per min after a short run Dec-14 0.995 1.000 1.000
Headache (=1) Jul/Aug- 14 1.000 1.000 1.000
Dizziness (=1) Jul/Aug- 14 0.990 1.000 1.000
Skin disease (=1) Jul/Aug- 14 0.947 1.000 0.947
Medical expenditure Jul/Aug- 14 1.000 1.000 1.000
Any visible burn (=1) Dec-14 1.000 1.000 1.000
Eye redness (=1) Dec-14 0.000 0.017 0.012
Eye irritation (=1) Dec-14 0.000 0.017 0.013
Teary eyes (=1) Dec-14 0.721 1.000 1.000
Dimness of vision (=1) Dec-14 0.998 1.000 1.000
